Samrat Pharmachem - Quaterly Results

14 Nov 2022 Evaluate
A fair growth of 20.38% in the revenue at Rs. 711.18 millions was reported in the September 2022 quarter as compared to Rs. 590.76 millions during year-ago period.The Total revenue for the quarter ended September 2022 of  Rs. 59.12  millions  grew by 112.05% from Rs. 27.88 millions.The company reported a good operating profit of 84.16 millions compared to 42.25 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 711.18 590.76 20.38 1576.25 1063.12 48.27 2218.12 1790.18 23.90
Other Income 1.59 0.72 120.83 1.84 2.27 -18.94 5.51 4.63 19.01
PBIDT 84.16 42.25 99.20 213.27 58.03 267.52 248.92 91.31 172.61
Interest 2.36 2.07 14.01 4.62 3.81 21.26 6.74 12.77 -47.22
PBDT 81.80 40.18 103.58 208.65 54.22 284.82 241.95 78.36 208.77
Depreciation 1.60 1.48 8.11 3.18 2.93 8.53 5.95 4.93 20.69
PBT 80.20 38.70 107.24 205.47 51.29 300.60 236.00 73.43 221.39
TAX 21.08 10.82 94.82 52.68 13.86 280.09 64.17 20.11 219.09
Deferred Tax -1.09 1.38 -178.99 -0.78 1.44 -154.17 0.28 2.88 -90.28
PAT 59.12 27.88 112.05 152.79 37.43 308.20 171.83 53.32 222.26
Equity 30.90 30.90 0.00 30.90 30.90 0.00 30.90 30.90 0.00
PBIDTM(%) 11.83 7.15 65.47 13.53 5.46 147.87 11.22 5.10 120.02

Samrat Pharmachem Share Price

253.30 1.00 (0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×